Skip to Main Content

Author Details

Kelly A Frazer
University of California, USA Institute for Genomic Medicine
1967
159
59
PMIDPaper TitleJournal TitlePublished Year
36854752Fine mapping spatiotemporal mechanisms of genetic variants underlying cardiac traits and disease.Nat Commun2023
37848026Single-nucleotide variants within heart enhancers increase binding affinity and disrupt heart development.Dev Cell2023
37903777eQTL mapping in fetal-like pancreatic progenitor cells reveals early developmental insights into diabetes risk.Nat Commun2023
37474502Author Correction: Fine mapping spatiotemporal mechanisms of genetic variants underlying cardiac traits and disease.Nat Commun2023
36854752Fine mapping spatiotemporal mechanisms of genetic variants underlying cardiac traits and disease.Nat Commun2023
37492100The human pangenome reference anticipates equitable and fundamental genomic insights.Cell Genom2023
37292794Analysis of regulatory network modules in hundreds of human stem cell lines reveals complex epigenetic and genetic factors contribute to pluripotency state differences between subpopulations.bioRxiv2023
37492100The human pangenome reference anticipates equitable and fundamental genomic insights.Cell Genom2023
37903777eQTL mapping in fetal-like pancreatic progenitor cells reveals early developmental insights into diabetes risk.Nat Commun2023
37848026Single-nucleotide variants within heart enhancers increase binding affinity and disrupt heart development.Dev Cell2023
37292794Analysis of regulatory network modules in hundreds of human stem cell lines reveals complex epigenetic and genetic factors contribute to pluripotency state differences between subpopulations.bioRxiv2023
37474502Author Correction: Fine mapping spatiotemporal mechanisms of genetic variants underlying cardiac traits and disease.Nat Commun2023
35226669In heart failure reactivation of RNA-binding proteins is associated with the expression of 1,523 fetal-specific isoforms.PLoS Comput Biol2022
36108770Systems genomics in age-related macular degeneration.Exp Eye Res2022
35705058SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues.Cell Rep2022
35603230Ultra-Sharp Nanowire Arrays Natively Permeate, Record, and Stimulate Intracellular Activity in Neuronal and Cardiac Networks.Adv Funct Mater2022
36778047Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines.Cell Genom2022
35226669In heart failure reactivation of RNA-binding proteins is associated with the expression of 1,523 fetal-specific isoforms.PLoS Comput Biol2022
35705058SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues.Cell Rep2022
35603230Ultra-Sharp Nanowire Arrays Natively Permeate, Record, and Stimulate Intracellular Activity in Neuronal and Cardiac Networks.Adv Funct Mater2022
36778047Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines.Cell Genom2022
36108770Systems genomics in age-related macular degeneration.Exp Eye Res2022
33252167Detection and validation of novel mutations in MERTK in a simplex case of retinal degeneration using WGS and hiPSC-RPEs model.Hum Mutat2021
34013287Insights into genetic factors contributing to variability in SARS-CoV-2 susceptibility and COVID-19 disease severity.medRxiv2021
34040254Enhancer release and retargeting activates disease-susceptibility genes.Nature2021
33505025Systematic analysis of binding of transcription factors to noncoding variants.Nature2021
33373444Genomics Links Inflammation With Neurocognitive Impairment in Children Living With Human Immunodeficiency Virus Type-1.J Infect Dis2021
33252167Detection and validation of novel mutations in MERTK in a simplex case of retinal degeneration using WGS and hiPSC-RPEs model.Hum Mutat2021
34662339Deciphering the genetic architecture and ethnographic distribution of IRD in three ethnic populations by whole genome sequence analysis.PLoS Genet2021
33505025Systematic analysis of binding of transcription factors to noncoding variants.Nature2021
34662339Deciphering the genetic architecture and ethnographic distribution of IRD in three ethnic populations by whole genome sequence analysis.PLoS Genet2021
34040254Enhancer release and retargeting activates disease-susceptibility genes.Nature2021
34013287Insights into genetic factors contributing to variability in SARS-CoV-2 susceptibility and COVID-19 disease severity.medRxiv2021
33373444Genomics Links Inflammation With Neurocognitive Impairment in Children Living With Human Immunodeficiency Virus Type-1.J Infect Dis2021
31582554Fibrinogen gamma gene <i>rs2066865</i> and risk of cancer-related venous thromboembolism.Haematologica2020
32075962Cellular deconvolution of GTEx tissues powers discovery of disease and cell-type associated regulatory variants.Nat Commun2020
32312984Author Correction: Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.Nat Commun2020
31582554Fibrinogen gamma gene <i>rs2066865</i> and risk of cancer-related venous thromboembolism.Haematologica2020
31992716Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.Nat Commun2020
32442913Genomic integrity of human induced pluripotent stem cells across nine studies in the NHLBI NextGen program.Stem Cell Res2020
33659414<i>In vitro</i> Differentiation of Human iPSC-derived Cardiovascular Progenitor Cells (iPSC-CVPCs).Bio Protoc2020
32873812Author Correction: Cellular deconvolution of GTEx tissues powers discovery of disease and cell-type associated regulatory variants.Nat Commun2020
32522985Discovery and quality analysis of a comprehensive set of structural variants and short tandem repeats.Nat Commun2020
32888420Revealing Instability: Genetic Variation Underlies Variability in mESC Pluripotency.Cell Stem Cell2020
33659414<i>In vitro</i> Differentiation of Human iPSC-derived Cardiovascular Progenitor Cells (iPSC-CVPCs).Bio Protoc2020
31992716Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.Nat Commun2020
32075962Cellular deconvolution of GTEx tissues powers discovery of disease and cell-type associated regulatory variants.Nat Commun2020
32888420Revealing Instability: Genetic Variation Underlies Variability in mESC Pluripotency.Cell Stem Cell2020
32873812Author Correction: Cellular deconvolution of GTEx tissues powers discovery of disease and cell-type associated regulatory variants.Nat Commun2020
32312984Author Correction: Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.Nat Commun2020
  • 1 - 50 of 318

Recommended Authors

Universitat de Barcelona (UB)
Career Start Year 2010
Number of shared co-authors 22
Berlin Institute of Health (BIH) at Charite-Universitatsmedizin Berlin
Career Start Year 2008
Number of shared co-authors 12
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 9
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2006
Number of shared co-authors 7
Scripps Science Institute
Career Start Year 2005
Number of shared co-authors 20
The Roslin Institute, The University of Edinburgh
Career Start Year 2005
Number of shared co-authors 11
Sanford School of Medicine, University of South Dakota
Career Start Year 2005
Number of shared co-authors 8
Regeneron Pharmaceuticals Inc.
Career Start Year 2004
Number of shared co-authors 80
University of Southern California
Career Start Year 2004
Number of shared co-authors 22
Columbia University
Career Start Year 2002
Number of shared co-authors 26
University of Texas M.D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 32
University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 35
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2001
Number of shared co-authors 46
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2000
Number of shared co-authors 23
National Human Genome Research Institute, National Institutes of Health
Career Start Year 2000
Number of shared co-authors 45
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 20
Icahn School of Medicine at Mount Sinai
Career Start Year 1998
Number of shared co-authors 65
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 16
University of Washington
Career Start Year 1997
Number of shared co-authors 33
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 1997
Number of shared co-authors 8
Harvard T.H. Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 10
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 7
University of Washington
Career Start Year 1996
Number of shared co-authors 33
University of Iceland
Career Start Year 1995
Number of shared co-authors 74
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 72
Center for Inherited Disease Research, Johns Hopkins School of Medicine
Career Start Year 1993
Number of shared co-authors 48
Stanford University School of Medicine
Career Start Year 1991
Number of shared co-authors 19
Institute for Systems Biology
Career Start Year 1988
Number of shared co-authors 35
Baylor College of Medicine
Career Start Year 1987
Number of shared co-authors 74
University of Washington
Career Start Year 1976
Number of shared co-authors 75

Collaborators

University of California
Co-authored papers 29
Department of Pediatrics and Rady's Children's Hospital, University of California
Co-authored papers 28
Rinat (Pfizer Inc.)
Co-authored papers 21
Institute for Genomic Medicine, University of California San Diego
Co-authored papers 16
Universidade Federal de Sao Paulo
Co-authored papers 13
23andMe Inc.
Co-authored papers 12
Stanford University
Co-authored papers 12
Co-authored papers 10
Co-authored papers 9
Department of Medicine and Moores Cancer Center, University of California San Diego
Co-authored papers 9
Memorial Sloan-Kettering Cancer Center
Co-authored papers 9
University of California San Diego
Co-authored papers 8
University of California San Diego Health System
Co-authored papers 8
Shiley Eye Institute, University of California San Diego
Co-authored papers 8
Herbert Wertheim School of Public Health, University of California San Diego
Co-authored papers 8
Co-authored papers 8
University of California San Diego
Co-authored papers 6
Ontario Institute for Cancer Research
Co-authored papers 6
University of California San Diego
Co-authored papers 6
Massachusetts General Hospital
Co-authored papers 6
Lawrence Berkeley National Laboratory
Co-authored papers 6
University of California San Diego
Co-authored papers 6
University of California San Diego
Co-authored papers 5
Co-authored papers 5
Center for Epigenomics, University of California San Diego
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
Moores Cancer Center, university of california san diego Health System
Co-authored papers 4
Vir Biotechnology Inc.
Co-authored papers 4
University of California san francisco
Co-authored papers 4